ArticleBMC cancer2005

Phase I dose-escalating study of docetaxel in combination with 5-day continuous infusion of 5-fluorouracil in patients with advanced gastric cancer.

Se Hoon Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.